Prairie View Partners, LLC Astrazeneca PLC Transaction History

Prairie View Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$54.21 - $70.44 $3,848 - $5,001	-71 Reduced 43.83%	91 $6,000
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $8,589 - $21,991	162 New	162 $9,000
Q1 2022 Apr 29, 2022	SELL	$55.72 - $67.12 $103,862 - $125,111	-1,864 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$54.02 - $63.83 $100,693 - $118,979	1,864 New	1,864 $109,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairie View Partners, LLC with notifications on news.